pe1
A Prospective Real-world Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin among People with Type 2 Diabetes Mellitus Who are Intolerant to Metformin (PRISM Study) Prabhat Kumar Agrawal, Ketan K Mehta, Abhisekh Raha, Rajesh Agarwal, Amit Varshney, Amitabh Biswas, Kiran Sharadchandra Shah, Aravinda Jagadeesha, Sher Singh Dariya, Bharat Saboo, Prabhakar Damodar Gokhale, Sandeep Suri, Kumar Prafull Chandra, Ashish Gautam, Harish Kumar B, Sonika Lamba, Prahlad Chawla, Nikhil Pursnani, Soumyaranjan Mohanty, Ruchika Garg Download
